Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04284007
Other study ID # MFM_IRB, MS.18.03.65 -
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date December 2, 2019
Est. completion date December 2020

Study information

Verified date February 2020
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interscalene brachial plexus block can be used as an additive to general anaesthesia or as the primary anaesthetic for shoulder surgeries for pain management.

The investigators compared the effect of perineural versus intravenous dexamethasone on the prolongation of the action of levobupivacaine in ultrasound guided interscalene block for shoulder and upper arm surgeries.


Description:

Dexamethasone had been shown to prolong the duration of postoperative analgesia when given as an adjuvant for peripheral nerve blocks.

The investigators compared the effect of perineural versus intravenous dexamethasone on the prolongation of the action of levobupivacaine in ultrasound guided interscalene block for shoulder and upper arm surgeries.

The study hypothesized that adding perineural dexamethasone to levobupivacaine in ultrasound guided interscalene block may be more superior to adding intravenous dexamethasone to levobupivacaine and levobupivacaine alone in shoulder and upper arm surgeries as regard analgesic effect, duration of analgesia and hemodynamic stability.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 90
Est. completion date December 2020
Est. primary completion date November 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists physical status grade I and grade II.

Exclusion Criteria:

- Patient refusal.

- Neuromuscular diseases (as myopathies, myasthenia gravies, …...)

- Hematological diseases, bleeding or coagulation abnormality.

- Psychiatric diseases.

- Local skin infection

- Sepsis at site of the block.

- Known intolerance to the study drugs.

- Body Mass Index > 40 Kg/m2

- contralateral phrenic palsy

- pneumothorax

- pneumectomy

- severe COPD

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Perineural levobupivacaine
Patients will receive 20 ml of 0.25% levobupivacaine plus 2ml saline in interscalene brachial plexus block plus 10 ml intravenous saline.
Perineural dexamethasone in addition to levobupivacaine
Patients will receive 20 ml of 0.25% levobupivacaine plus 4mg dexamethasone diluted in 2 ml saline in interscalene brachial plexus block plus 10 ml intravenous saline.
Intravenous dexamethasone with perineural levobupivacaine
Patients will receive 20 ml of 0.25% levobupivacaine plus 2ml saline in interscalene brachial plexus block plus 4 mg intravenous dexamethasone diluted in 10 ml saline.

Locations

Country Name City State
Egypt Mansoura University Mansourah Dakhlia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of postoperative analgesia as measured by time to first analgesic requirement. for 24 hour postoperatively
Secondary Onset of Sensory block Patients will be closely observed until 30 minutes after the end of local anesthetic injection. Block success will be defined as loss of sensation to pinprick in the C4 and C5 sensory dermatome distribution measured 30 minutes after the end of local anesthetic injection. sensory block will be assessed by pin prick test using a 3point scale: • Grade 0 = Normal sensation.
Grade 1 = loss of sensation to pin prick (analgesia).
Grade 2 = loss of sensation to touch (anaesthesia). Onset time for sensory block will be defined as the time interval between the end of local anaesthesia administration and complete sensory block (score 2).
For 30 min after injecting local anesthetic
Secondary Duration of sensory block defined as the time interval between complete sensory block (score 2) and complete resolution of anaesthesia on all nerves (score 0) within 24 hours after the surgery.
Secondary Onset time of motor block Motor block will be determined according to the modified Bromage scale:
Grade 0 = Normal motor function with full flexion and extention of elbow.
Grade 1 = Decrease motor power.
Grade 2 = Complete motor block. Onset time of motor block will be defined as the time interval between end of local anaesthetic administration and complete motor block (grade 2).
For 30 min after injecting local anesthic
Secondary Duration of motor block defined as the time interval between complete motor block (score 2) and complete recovery of motor function of the arm (score 0). within 24 hours after the surge
Secondary Intraoperative Heart rate changes Heart rate changes For 3 hours after surgery
Secondary Intraoperative Mean arterial blood pressure changes Mean arterial blood pressure changes For 3 hours after surgery
Secondary Intraoperative analgesic consumption the intraoperative analgesic dose consumption would be calculated The investigators can use fentanyl as analgesic if the patient required during the surgery ( 50-100 mic) For 3 hours after surgery
Secondary Postoperative heart rate changes For one hour after admission to the postoperative anesthesia care unit
Secondary Postoperative Mean arterial blood pressure changes For one hour after admission to the postoperative anesthesia care unit
Secondary Postoperative peripheral oxygen saturation changes For one hour after admission to the postoperative anesthesia care unit
Secondary Pain score The VAS is represented with straight line with one end has the anchor " no pain" and it takes 0, while the other end of the line has the anchor " pain as bad as it could be" and it takes 10.
The patient will receive the rescue analgesic when the score is more than 4)
Pain after surgery will be assessed using VAS at 1,2,6,12 and 24 hours.
Secondary Total analgesic need and the onset of first intravenous analgesia Total analgesic need to rescue analgesic (pethidine) calculated by mg. And the onset of time for first intravenous analgesia during the 24 hours postoperative by hours. After transportation of the patient from PACU up to 24 hours postoperative.
Secondary Patient satisfaction: 2-point scale concerning the procedure is assessed using a 2-point scale (1= satisfied, I would want the same anesthesia / analgesia method for the next surgery, 2= unsatisfied, I would want a different anesthesia / analgesia method for the next surgery). first 24 hours postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT04930393 - Evaluating the Efficacy of PECS II Block Versus Axillary Ring Block in Rotator Cuff Repair Patients N/A
Completed NCT03717753 - Rotator Cuff Pathway N/A
Completed NCT04454671 - Ultrasound-guided Percutaneous Neuromodulation Versus Dry Needling in Shoulder Pain Treatment N/A
Completed NCT06274827 - Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises N/A
Not yet recruiting NCT05413213 - Ambulatory Rehabilitation Program in Patients With Degenerative Rupture of the Rotator Cuff Tendons of the Shoulder N/A
Not yet recruiting NCT05043844 - Comparison of the Incidence of Shoulder Pain According to Postoperative Use of Abdominal Binder N/A
Recruiting NCT02903719 - The Effect of Phrenic Nerve Block on Postoperative Shoulder Pain in Patients for Liver Resection. Phase 4
Completed NCT02777281 - Safe and Effective Shoulder Exercise Training in Manual Wheelchair Users With SCI N/A
Completed NCT02554968 - Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer
Recruiting NCT02242630 - Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis N/A
Active, not recruiting NCT02843269 - Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM N/A
Completed NCT02631395 - The Effect of a Shoulder Training Program to Prevent Shoulder Pain Among Girls in Junior Team Handball N/A
Completed NCT01733914 - Contralateral Acupuncture in the Treatment of Chronic Shoulder Pain Phase 2
Completed NCT01885377 - SWESS: The SWedish Exercise Shoulder Study in Primary Care for Patients With Subacromial Pain N/A
Completed NCT01205542 - Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Shoulder Function N/A
Completed NCT01843660 - An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain Phase 4
Completed NCT00743600 - Ultrasound Evaluation of the Rotator Cable and Associated Structures. N/A
Completed NCT00679887 - Chronic Shoulder Pain Treated by Pressures With the Thumbs on the Trigger Points Phase 1/Phase 2
Completed NCT04058522 - Treatment of Subacromial Shoulder Pain by Individual or Group Physiotherapy Following Corticosteroid Injection N/A
Completed NCT03353272 - The Influence of a Cognitive Behavioral Approach on Changing Patient Expectations in Shoulder Pain N/A